News | January 25, 2022
Control Print’s 3-ply surgical masks receive USFDA 510(K) authorisation
The company has been manufacturing masks since the Covid-19 outbreak in 2020
The company has been manufacturing masks since the Covid-19 outbreak in 2020
Phase 1/2 trial of E-602 expected to open in Q1 2022 in patients with solid tumours
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
The extended collaboration will provide services relating to small molecules for both Forbion and BGV portfolio companies active in the biopharmaceutical space
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
Under the terms of the agreement, Arrakis will lead research activities for the identification of RNA-targeted small molecule (rSM) binders against a broad set of targets nominated by Amgen
Cobas infinity edge is designed as an open platform, allowing healthcare professionals to easily access and adopt third-party innovators’ new digital tools and medically-relevant applications via the Roche digital marketplace
Carisma to receive US $ 45 million up-front cash payment and investment by Moderna in the form of a US $ 35 million convertible note
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management
Subscribe To Our Newsletter & Stay Updated
